Merck Kgaa Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   EUR per share 
 Price  89.98
 Dividend  1.25
 Earnings  8.82
 Cash-flow  6.21
 Book value  31.03
 Equity  31.17

Merck Kgaa is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Merck Kgaa is a company from Germany, and his stocks are publicly traded.

Merck Kgaa paid a total dividend of 161 million EUR last year, for a market value of 11,607 millions (Market Cap 11,625 millions). Dividend per share of Merck Kgaa is 1.25 EUR, and his stock market price 89.98 EUR.

According to the chart below, where dividend yield is displayed, Merck Kgaa has a dividend yield of 1.39%, lower than the amount offered by both the market average and companies from Germany. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Merck Kgaa dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Germany.

Dividend yield of Merck Kgaa

Merck Kgaa Dividend Payout

About the ability of Merck Kgaa to maintain his current dividend of EUR 1.25 per share, an amount that accounts for 1.39%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Merck Kgaa payout on ernings is currently 14.17%, which is lower than the market average and companies of Health Care industry, which are 40.41% and 28.58% respectively. Both figures lead us to believe that there is confidence that Merck Kgaacan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Merck Kgaa is EUR 6.21 per share, which is higher than the dividend per share paid by the company of EUR 1.25, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Merck Kgaa, compared againt world market average, Germany companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Merck Kgaa payout

Merck Kgaa Stock performance

Finally, last moth Merck Kgaa showed a return of -7.60% compared to a worldwide -5.60% average, and a -7.73% of Health Care firms. Over the last year, the company obtained a 0.30% versus a worldwide performance of a -11.41%. More detailed information can be seen in the following graph for Germany and Pharmaceuticals and Biotechnology firms.

Merck Kgaa stock and market return

Next companies

Meridian Energy. New Zealand. Utilities.

Merlin Entertainment. UK. Consumer Services.

Merlin Properties Socimi SA. Spain. Financials.

Metallurgical Corp.. China. Industrials.

Metcash. Australia. Consumer Services.

Metlife. USA. Financials.

Previous companies

Merck & Co. USA. Health Care.

MercadoLibre Inc.. USA. Consumer Services.

Melrose Industries. UK. Industrials.

Melrose Industries. UK. Industrials.

Melker Schoerling AB. Sweden. Financials.

Melisron. Israel. Financials.



All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.